PRODUCTION OF INTERFERON BY HUMAN-TUMOR CELL-LINES

被引:20
|
作者
JAMESON, P
GROSSBERG, SE
机构
[1] Department of Microbiology, The Medical College of Wisconsin, Milwaukee, Wisconsin
关键词
D O I
10.1007/BF01317553
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Fourteen continuous human cell lines, including nine derived from tumors and five from non-neoplastic tissues, produced interferon in response to induction with bluetongue virus (BTV), Newcastle disease virus (NDV), and poly(I) · poly(C) complexed with DEAE-dextran. The seven best interferon-producing cell lines (one from a melanoma, five derived from carcinomas, and one SV40-virus-transformed kidney cell line) responded to at least one of the viral inducers with yields of interferon over 1000 units/ml. Because the HT-1376 bladder carcinoma cell line produced high yields of interferon in this survey, and is easily propagated, the optimal conditions for interferon production were investigated, using BTV as the inducer. Interferon yields in 59 inductions over a period of about two years consistently fell within a 6-fold range, and had a geometric mean titer of about 2700 reference units (RU)/ml, representing the production of about 3 RU/103 cells. This yield is comparable to mean titers of 1 to 10 RU/103 cells obtained by others with human leukocytes, foreskin cell strains, or the Namalva lymphoblastoid cell line. UV-inactivated BTV at a multiplicity corresponding to 10 PFU/cell was as effective an inducer in the HT-1376 cell line as the fully infectious virus at a multiplicity of 1 PFU/cell. The interferon produced by the HT-1376 epithelial cell line has characteristics similar to the interferon induced by poly(I) · poly(C) in human diploid fibroblasts. These studies clearly demonstrate that many different types of tumor-derived cells have the capacity to produce interferon, and that some equal or surpass the efficiency of diploid cells. © 1979 Springer-Verlag.
引用
收藏
页码:209 / 219
页数:11
相关论文
共 50 条
  • [31] 3 DIFFERENT HUMAN-TUMOR CELL-LINES CONTAIN DIFFERENT ONCOGENES
    MURRAY, MJ
    SHILO, BZ
    SHIH, C
    COWING, D
    HSU, HW
    WEINBERG, RA
    CELL, 1981, 25 (02) : 355 - 361
  • [32] DETECTION AND CONTROL OF OCCULT MYCOPLASMA CONTAMINATION IN HUMAN-TUMOR CELL-LINES
    DENT, PB
    CLELAND, GB
    LIAO, SK
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1980, 8 (01) : 27 - 32
  • [33] DIRECT ANTIPROLIFERATIVE EFFECTS OF RECOMBINANT HUMAN INTERFERON-ALPHA B/D HYBRIDS ON HUMAN-TUMOR CELL-LINES
    FIDLER, IJ
    HEICAPPELL, R
    SAIKI, I
    GRUTTER, MG
    HORISBERGER, MA
    NUESCH, J
    CANCER RESEARCH, 1987, 47 (08) : 2020 - 2027
  • [34] MULTICELLULAR AGGREGATES FROM HUMAN-TUMOR CELL-LINES FOR RADIATION STUDIES
    SCHWACHOFER, JHM
    CROOIJMANS, RPMA
    BROERS, JLV
    HOOGENHOUT, J
    JERUSALEM, CR
    JERUSALEM, R
    KAL, HB
    MUNGYER, G
    ANTICANCER RESEARCH, 1989, 9 (02) : 441 - 448
  • [35] BOMBESIN-LIKE PEPTIDES AND RECEPTORS IN HUMAN-TUMOR CELL-LINES
    MOODY, TW
    BERTNESS, V
    CARNEY, DN
    PEPTIDES, 1983, 4 (05) : 683 - 686
  • [36] CYTOGENETICS OF 52 HUMAN-TUMOR CELL-LINES GROWN-INVITRO
    HUKKU, B
    ELMORE, N
    AARONSON, SA
    PETERSON, WD
    CANCER GENETICS AND CYTOGENETICS, 1986, 19 (1-2) : 185 - 185
  • [37] DEVELOPMENT OF ALKYLATING AGENT-RESISTANT HUMAN-TUMOR CELL-LINES
    TEICHER, BA
    FREI, E
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 21 (04) : 292 - 298
  • [38] HUMAN-TUMOR CELL-LINES ESTABLISHED USING CLONAL AGAR CULTURE
    BERTONCELLO, I
    BRADLEY, TR
    WEBBER, LM
    HODGSON, GS
    CAMPBELL, JJ
    AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1985, 63 (APR): : 241 - 248
  • [39] MUTATION AND DRUG-RESISTANCE IN HUMAN-TUMOR CELL-LINES INVITRO
    PARRIS, CN
    MASTERS, JRW
    BRITISH JOURNAL OF CANCER, 1988, 58 (02) : 233 - 233
  • [40] RESPONSE OF HUMAN-TUMOR CELL-LINES INVITRO TO FRACTIONATED-IRRADIATION
    MATTHEWS, JHL
    MEEKER, BE
    CHAPMAN, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (01): : 133 - 138